Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Enterprise Technology
  • Contract Manufacturing
  • R&D 100 Awards

Lonza to Divest Water Care Business for $630M

By Lonza Group Ltd | November 1, 2018

Platinum Equity has entered into a definitive agreement to acquire Lonza’s Water Care business and operations for $630 million. The inclusion of the French business in the transaction is still under discussion.

With headquarters in Alpharetta, GA, Water Care has six manufacturing facilities in key regions, including North America, South America, EMEA, and South Africa, with sales locations in all regions globally and with approximately 1,200 employees.

The business provides water treatment products for residential pool care and serves high-growth industrial and municipal water care markets.

“We are putting the Water Care business in the hands of an experienced owner who will develop Water Care as a stand-alone business while focusing on innovation and further growth,” said Richard Ridinger, CEO of Lonza. “The divestment further strengthens our strategic focus on our three core pillars—Pharma & Biotech, Consumer Health, and Consumer & Resources Protection—within the healthcare continuum.”

Lonza had announced in May that it had retained an investment bank to advise on all strategic options regarding its Water Care business as part of an active portfolio management approach. The strategic review was publicly confirmed at Lonza’s Capital Markets Day in September. 

Lonza acquired the Water Care business as part of its acquisition of Arch Chemicals in 2011 and developed it as part of the Specialty Ingredients segment.

Platinum Equity is a global private equity firm with approximately $13 billion of assets under management and a highly specialized focus on business operations. The firm has carve-out expertise, with experience acquiring and operating businesses that have been part of large corporate entities. Last month, the company completed a $2.1 billion acquisition of LifeScan from Johnson & Johnson.

Water Care’s business unit head Christian Wichert and his management team will continue to lead the business, according to Platinum Equity.

The agreement is expected to close in the first quarter of 2019, subject to customary closing conditions.

(Source: Lonza Group Ltd.)

Related Articles Read More >

Biden’s COVID-19 response will make manufacturers busy
Catalent
Catalent to acquire Acorda’s manufacturing and packaging operations 
Halix
Halix to help make AstraZeneca’s COVID-19 vaccine
Lantheus Holdings
Lantheus sells radiopharmacy and PET manufacturing facility to PharmaLogic

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup

R&D Twitter

Tweets by @RandDWorld
Pharmaceutical Processing World
  • Enews Signup
  • Contact Us
  • About Us
  • R&D World
  • DeviceTalks
  • Drug Discovery & Development
  • Drug Delivery Business News
  • MassDevice
  • Medical Design Sourcing

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Enterprise Technology
  • Contract Manufacturing
  • R&D 100 Awards